Flurbiprofen 100 MG Oral Tablet — RxCUI 197724
RxNorm drug concept · Semantic clinical drug
RxCUI 197724
Semantic clinical drug · SCD
● Current RxNorm concept 3 FDA products
3 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI197724
Official nameFlurbiprofen 100 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped3
Package NDCs mapped3
Reported Medicaid activity (SDUD)1,421 prescriptions · 16 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Flurbiprofen Ophthalmic: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- These drops are used right before eye surgery to keep your pupil from getting smaller during the procedure. When surgeons operate on the eye, they need a wide, stable pupil for a c...
- No — these are not drops you use at home. Your surgical team administers them in the clinic or hospital before your procedure. They'll put in one drop every 30 minutes, starting 2...
- Some people notice a brief burning or stinging sensation right when the drops are instilled — this is the most commonly reported side effect and usually passes quickly. A little ey...
- Will I feel anything when the drops go in?
🕸️ Concept Web — How Flurbiprofen 100 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Flurbiprofen 100 MG Oral Tablet
RxCUI 197724 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Flurbiprofen
4502IN
-
Flurbiprofen
-
Brand names 3
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Ansaid
203411BN -
Lurbipr
2712487BN -
Lurbiro
2720350BN
-
Ansaid
-
Dose forms 15
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Flurbiprofen Oral Tablet
372249SCDF -
Flurbiprofen Oral Product
1161453SCDG -
Flurbiprofen Pill
1161454SCDG -
Flurbiprofen Oral Tablet [Ansaid]
369463SBDF -
Flurbiprofen Oral Tablet [Lurbipr]
2712491SBDF -
Flurbiprofen Oral Tablet [Lurbiro]
2720354SBDF -
Ansaid Oral Product
1176829SBDG -
Ansaid Pill
1176830SBDG - +7 more in this family
-
Flurbiprofen Oral Tablet
-
Clinical & branded drugs 7
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Flurbiprofen 100 MG
315958SCDC -
Flurbiprofen 100 MG Oral Tablet [Ansaid]
205626SBD -
Flurbiprofen 100 MG Oral Tablet [Lurbipr]
2712492SBD -
Flurbiprofen 100 MG Oral Tablet [Lurbiro]
2720355SBD -
Flurbiprofen 100 MG [Ansaid]
566518SBDC -
Flurbiprofen 100 MG [Lurbipr]
2712488SBDC -
Flurbiprofen 100 MG [Lurbiro]
2720351SBDC
-
Flurbiprofen 100 MG
Showing up to 8 concepts per family — 19 of 26 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Flurbiprofen 100 MG
SCDC · 315958 -
Flurbiprofen Oral Tablet
SCDF · 372249 -
Flurbiprofen Oral Product
SCDG · 1161453 -
Flurbiprofen Pill
SCDG · 1161454
Brand-Name Concepts
-
Flurbiprofen 100 MG Oral Tablet [Lurbiro]
SBD · 2720355 -
Flurbiprofen 100 MG Oral Tablet [Ansaid]
SBD · 205626 -
Flurbiprofen 100 MG Oral Tablet [Lurbipr]
SBD · 2712492 -
Flurbiprofen 100 MG [Ansaid]
SBDC · 566518 -
Flurbiprofen 100 MG [Lurbipr]
SBDC · 2712488 -
Flurbiprofen 100 MG [Lurbiro]
SBDC · 2720351 -
Flurbiprofen Oral Tablet [Ansaid]
SBDF · 369463 -
Flurbiprofen Oral Tablet [Lurbipr]
SBDF · 2712491 -
Flurbiprofen Oral Tablet [Lurbiro]
SBDF · 2720354 -
Ansaid Oral Product
SBDG · 1176829
📦 FDA Products & Package NDCs
3 products · 3 package NDCs
3 package NDCs map to RxCUI 197724 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 64950-0218-10 | 100 TABLET in 1 BOTTLE (64950-218-10) | Flurbiprofen | Genus Lifesciences | 2024-11-01 |
| 68071-4436-04 | 14 TABLET, FILM COATED in 1 BOTTLE (68071-4436-4) | Flurbiprofen | NuCare Pharmaceuticals,Inc. | 2018-05-17 |
| 71085-0082-30 | 30 TABLET in 1 BOTTLE (71085-082-30) | LURBIRO | IPG Pharmaceuticals, Inc. | 2025-08-01 |
Observed labelers:
Genus Lifesciences (1) ·
IPG Pharmaceuticals, Inc. (1) ·
NuCare Pharmaceuticals,Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.